BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36768939)

  • 21. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
    Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
    Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
    Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
    Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological classification of canine mammary tumor based on quantifying mRNA levels of hormonal receptors, SATB1, and Snail in tissue and fine needle biopsy samples.
    Komatsu T; Iwano H; Ebisawa M; Watabe A; Endo Y; Hirayama K; Taniyama H; Kadosawa T
    J Vet Med Sci; 2012 Jun; 74(6):719-26. PubMed ID: 22230980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between DLA-DRB1.2 allelic diversity and development of mammary gland tumors in dogs.
    Vahedi SM; Nikbakht G; Jamshidi S; Lankarani L; Alimi N; Esmailnejad A
    Acta Vet Scand; 2019 Nov; 61(1):55. PubMed ID: 31727096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs.
    Fish EJ; Martinez-Romero EG; DeInnocentes P; Koehler JW; Prasad N; Smith AN; Bird RC
    J Vet Intern Med; 2020 May; 34(3):1282-1290. PubMed ID: 32342546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
    Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
    Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
    Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
    PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.
    Lutful Kabir FM; DeInnocentes P; Bird AC; Bird RC
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):519-530. PubMed ID: 34014456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
    DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
    Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling canine mammary tumors: A potential model for studying human breast cancer.
    Gherman LM; Chiroi P; Nuţu A; Bica C; Berindan-Neagoe I
    Vet J; 2024 Feb; 303():106055. PubMed ID: 38097103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.
    Lutful Kabir FM; DeInnocentes P; Bird RC
    J Cell Biochem; 2015 Dec; 116(12):2956-69. PubMed ID: 26095675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and prognostic value of TRPM7 in canine mammary tumours.
    Lee S; Lee S; Kim WH
    Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
    Klopfleisch R; Lenze D; Hummel M; Gruber AD
    Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
    Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS
    Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
    Sakai K; Yonezawa T; Yamawaki H; Oyamada T
    J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of mammaglobin-B in canine mammary tumors.
    Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
    BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
    Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
    J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
    Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
    Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.